Post by
Petey78 on Mar 11, 2021 7:59am
Markus
So this clown started with MedMira around 2014. The stock was cruising around $0.07'ish for the longest time. Nothing significant happened since the early 2000's.
Then Covid hit. Medmira supposedly had a great rapid test. Why didn't this stock move like others? Since 2014, the stock has only moved to $0.20's. (Disregard the temporary highs).
Why didn't it get FDA, EUA, or HC approval? Did someone eff up the paperwork? This Chan guy seems to have good innovation (HVI tests). He just needs a real CPA as his CFO. Get rid of this clown.